
( (SINV 
    (S-TPC-1 
      (NP-SBJ 
        (NP (DT A) (VBN proposed) (NN conflict-of-interest) (NN policy) )
        (PP (IN for) 
          (NP 
            (ADJP (RB federally) (VBN funded) )
            (JJ biomedical) (NNS researchers) )))
      (VP (MD may) 
        (VP (VB thwart) 
          (NP (JJ many) (NN high-technology) (JJ new) (NNS ventures) ))))
    (, ,) 
    (VP (VBP say) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (NP-SBJ 
      (NP (NNS financiers) )
      (, ,) 
      (NP (NNS researchers) )
      (CC and) 
      (NP (NN university) (NNS administrators) ))
    (. .) ))
( (S 
    (NP-SBJ (DT The) 
      (NAC (NNP National) (NNPS Institutes) 
        (PP (IN of) 
          (NP (NNP Health) )))
      (NN policy) )
    (VP (MD would) 
      (VP (VB require) 
        (S 
          (NP-SBJ (NNS researchers) )
          (VP (TO to) 
            (VP 
              (VP (VB cut) 
                (NP 
                  (NP (JJ financial) (NNS ties) )
                  (PP (IN with) 
                    (NP (JJ health-care) (NNS businesses) ))))
              (: --) (CC or) 
              (VP (VB lose) 
                (NP (PRP$ their) (NN government) (NN money) )))))))
    (. .) ))
( (S 
    (PP (IN Among) 
      (NP (JJ other) (NNS concerns) ))
    (, ,) 
    (NP-SBJ (DT the) (NN agency) )
    (VP (VBZ says) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ-1 
            (NP (NNS researchers) )
            (PP (IN with) 
              (NP (NN business) (NNS ties) )))
          (VP (VBP are) 
            (ADJP-PRD (RBR more) (JJ likely) 
              (S 
                (NP-SBJ-2 (-NONE- *-1) )
                (VP (TO to) 
                  (VP (VB falsify) 
                    (NP (NNS findings) )
                    (SBAR-PRP (IN in) (NN order) 
                      (S 
                        (NP-SBJ (-NONE- *-2) )
                        (VP (TO to) 
                          (VP (VB tout) 
                            (NP (JJ new) (NNS drugs) )))))))))))))
    (. .) ))
( (S 
    (SBAR-TMP (IN As) 
      (S 
        (NP-SBJ 
          (NP (NNS ties) )
          (PP (IN between) 
            (NP 
              (NP (NN academia) )
              (CC and) 
              (NP (NN venture) (NN capital) ))))
        (VP (VBP have) 
          (VP (VBN blossomed) 
            (PP-TMP (IN in) 
              (NP (JJ recent) (NNS years) ))))))
    (, ,) 
    (NP-SBJ 
      (NP (JJ governmental) (NN fear) )
      (PP (IN of) 
        (NP (NN abuse) )))
    (VP (VBZ has) 
      (VP (VBN risen) ))
    (. .) ))
((SINV 
    (S-TPC-1 (CC But) 
      (NP-SBJ (DT the) (NNS guidelines) )
      (VP (MD could) (`` ``) 
        (VP (VB make) 
          (S 
            (NP-SBJ 
              (NP (PRP it) )
              (S (-NONE- *EXP*-2) ))
            (ADJP-PRD (JJ impossible) )
            (S-2 
              (NP-SBJ (-NONE- *) )
              (VP (TO to) 
                (VP (VB commercialize) 
                  (NP (NN research) ))))))))
    (, ,) ('' '') 
    (VP (VBZ says) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (NP-SBJ 
      (NP (NNP Kenneth) (NNP Smith) )
      (, ,) 
      (NP 
        (NP (JJ associate) (NN provost) )
        (CC and) 
        (NP 
          (NP (NN vice) (NN president) )
          (PP (IN for) 
            (NP (NN research) )))
        (PP-LOC (IN at) 
          (NP 
            (NP (NNP Massachusetts) (NNP Institute) )
            (PP (IN of) 
              (NP (NNP Technology) ))))))
    (. .) ))
( (S 
    (NP-SBJ (DT The) (NNP NIH) )
    (VP (VBZ is) 
      (VP (VBG asking) 
        (NP 
          (NP (NN grant) (NNS recipients) )
          (CC and) 
          (NP (NNS others) ))
        (PP-CLR (IN for) 
          (NP 
            (NP (NNS comments) )
            (PP (IN on) 
              (NP (DT the) (VBN proposed) (NNS guidelines) ))))
        (PP-TMP (IN until) 
          (NP (NNP Dec.) (CD 15) ))))
    (. .) ))
( (S 
    (PP-TMP (IN After) 
      (NP (DT that) ))
    (, ,) 
    (NP-SBJ (PRP it) )
    (VP (MD will) 
      (VP (VB make) 
        (NP 
          (NP (DT a) (JJ final) (NN decision) )
          (PP (IN on) 
            (NP (DT the) (NN policy) )))))
    (. .) ))
((SINV 
    (S-TPC-1 
      (NP-SBJ (DT The) (NNS guidelines) )
      (VP (MD could) 
        (VP (VB foil) 
          (NP 
            (NP (JJ future) (NNS arrangements) )
            (ADJP (JJ similar) 
              (PP (TO to) 
                (NP 
                  (NP (DT the) (NN deal) )
                  (PP (IN behind) 
                    (NP 
                      (NP (NNP Lithox) (NNP Inc.) )
                      (, ,) 
                      (NP (DT a) 
                        (NAC-LOC (NNP Salem) 
                          (, ,)
                          (NNP Mass.) 
                          (, ,)
                          )
                        (NN start-up) ))))))))))
    (, ,) 
    (VP (VBZ says) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (NP-SBJ 
      (NP (NNP Robert) (NNP Daly) )
      (, ,) 
      (NP 
        (NP (DT a) (VBG managing) (NN partner) )
        (PP (IN of) 
          (NP 
            (NP (NNP TA) (NNPS Associates) )
            (, ,) 
            (NP (DT a) (JJ venture-capital) (NN firm) )))))
    (. .) ))
( (S 
    (PP (IN With) 
      (NP 
        (QP ($ $) (CD 2.3) (CD million) )
        (-NONE- *U*) ))
    (, ,) 
    (NP-SBJ 
      (NP (PRP he) )
      (CC and) 
      (NP (JJ other) (NNS investors) ))
    (VP (VBD launched) 
      (NP-1 (NNP Lithox) )
      (NP-TMP (JJ last) (NN year) )
      (S-PRP 
        (NP-SBJ (-NONE- *-1) )
        (VP (TO to) 
          (VP (NN market) 
            (NP 
              (NP (DT a) (NN gallstone) (NN cure) )
              (VP (NN being) 
                (VP (VBN developed) 
                  (NP (-NONE- *) )
                  (PP (IN by) 
                    (NP-LGS 
                      (NP (NNS researchers) )
                      (PP (IN of) 
                        (NP 
                          (NP (DT the) (NNP University) )
                          (PP (IN of) 
                            (NP (NNP California) ))
                          (PP-LOC (IN at) 
                            (NP (NNP San) (NNP Diego) )))))))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (DT The) (NNS researchers) )
      (, ,) 
      (SBAR 
        (WHNP-2 (WP who) )
        (S 
          (NP-SBJ-1 (-NONE- *T*-2) )
          (VP (VBP are) 
            (VP (VBG being) 
              (VP (VBN financed) 
                (NP (-NONE- *-1) )
                (PP (IN by) 
                  (NP-LGS (DT the) (NNP Lithox) (NNS funds) )))))))
      (, ,) )
    (VP (MD will) 
      (VP (VB receive) 
        (NP (DT a) 
          (NX 
            (NX (NN royalty) )
            (, ,) (CC or) 
            (NX 
              (NX (NN percentage) )
              (PP (IN of) 
                (NP (NNS sales) )))
            (, ,) ))
        (SBAR-ADV (IN if) 
          (S 
            (NP-SBJ (PRP$ their) (NN research) )
            (VP (VBZ yields) 
              (NP (DT a) (JJ commercial) (NN product) ))))))
    (. .) ))
( (S 
    (S-TPC-1 (CC But) 
      (SBAR-PRP (IN because) 
        (S 
          (NP-SBJ 
            (NP (DT the) (NNP University) )
            (PP (IN of) 
              (NP (NNP California) )))
          (, ,) 
          (PP (IN like) 
            (NP (JJ many) (JJ other) (NNS universities) ))
          (, ,) 
          (VP (VBZ shares) 
            (NP (PRP$ its) (NNS royalties) )
            (PP (IN with) 
              (NP (NNS researchers) )))))
      (, ,) 
      (NP-SBJ (PRP it) )
      (VP (MD may) 
        (VP (VB disqualify) 
          (NP (PRP itself) )
          (PP-CLR (IN from) 
            (NP (JJ federal) (NNS funds) ))
          (PP-LOC (IN under) 
            (NP (DT the) (VBN proposed) (NNS guidelines) ))))
      (, ,) )
    (NP-SBJ (NNP Mr.) (NNP Daly) )
    (VP (VBZ says) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (. .) ))
( (S 
    (NP-SBJ (DT The) (JJ high-tech) (NN industry) )
    (VP (VBZ is) 
      (ADJP-PRD (JJ full) 
        (PP (IN of) 
          (NP 
            (NP (DT the) (NN kind) )
            (PP (IN of) 
              (NP (NN arrangement) ))
            (SBAR 
              (WHNP-1 (IN that) )
              (S 
                (NP-SBJ (DT the) (JJ new) (NNS guidelines) )
                (VP (MD would) 
                  (VP (VB affect) 
                    (NP (-NONE- *T*-1) )))))))))
    (. .) ))
( (S 
    (PP (IN For) 
      (NP (NN instance) ))
    (, ,) 
    (NP-SBJ-2 
      (NP (NNP Commonwealth) (NNP BioVentures) (NNP Inc.) )
      (, ,) 
      (NP (DT a) (JJ venture-capital) (NN concern) )
      (, ,) )
    (NP-TMP (JJ last) (NN month) )
    (VP (VBD invested) 
      (NP ($ $) (CD 600,000) (-NONE- *U*) )
      (S-PRP-CLR 
        (NP-SBJ (-NONE- *-2) )
        (VP (TO to) 
          (VP (VB launch) 
            (NP 
              (NP (NNP Amira) (NNP Inc.) )
              (, ,) 
              (NP 
                (NP (DT a) 
                  (NAC-LOC (NNP Worcester) 
                    (, ,)
                    (NNP Mass.) 
                    (, ,)
                    )
                  (NN concern) )
                (SBAR 
                  (WHNP-1 (WDT that) )
                  (S 
                    (NP-SBJ (-NONE- *T*-1) )
                    (VP (MD will) 
                      (VP (VB produce) 
                        (NP (NNS pharmaceuticals) )))))))))))
    (. .) ))
( (S 
    (NP-SBJ (NNS Scientists) (NNP Rima) (NNP Kaddurah-Daouk) 
      (CC and)
      (NNP Paul) (NNP Schimmel) )
    (VP (VBD conducted) 
      (NP (DT the) (JJ initial) (NN research) )
      (PP-LOC (IN at) 
        (NP 
          (NP (DT the) (NNP Massachusetts) (NNP Institute) )
          (PP (IN of) 
            (NP (NNP Technology) )))))
    (. .) ))
( (S 
    (SBAR-ADV (IN While) 
      (S 
        (NP-SBJ-2 (NNP Ms.) (NNP Kaddurah-Daouk) )
        (VP (VBD left) 
          (NP (NNP MIT) )
          (S-PRP 
            (NP-SBJ (-NONE- *-2) )
            (VP (TO to) 
              (VP (VB head) 
                (NP (NNP Amira) )))))))
    (, ,) 
    (NP-SBJ-1 (NNP Prof.) (NNP Schimmel) )
    (VP (MD will) 
      (VP (VB continue) 
        (S 
          (NP-SBJ (-NONE- *-1) )
          (VP (TO to) 
            (VP 
              (VP (VB work) 
                (PP-LOC (IN at) 
                  (NP (NNP MIT) )))
              (, ,) 
              (VP (VB serve) 
                (PP-CLR (IN on) 
                  (NP 
                    (NP (NNP Amira) (POS 's) )
                    (NN board) )))
              (CC and) 
              (VP (VB own) 
                (NP 
                  (NP (DT a) (JJ small) (NN equity) (NN stake) )
                  (PP (IN in) 
                    (NP (DT the) (NN company) )))))))))
    (. .) ))
( (S 
    (NP-SBJ (DT The) (NNP Amira) (NN transaction) )
    (VP (VBZ is) 
      (ADJP-PRD (JJ typical) 
        (PP (IN of) 
          (NP 
            (NP (DT the) (NN way) )
            (SBAR 
              (WHADVP-1 (-NONE- 0) )
              (S 
                (NP-SBJ (JJ venture-capital) (NNS firms) )
                (VP (VBP are) 
                  (VP (VBG approaching) 
                    (NP 
                      (NP (DT the) (NN task) )
                      (PP (IN of) 
                        (S-NOM 
                          (NP-SBJ (-NONE- *) )
                          (VP (VBG commercializing) 
                            (NP (NN biotechnology) (NN research) )))))
                    (ADVP-MNR (-NONE- *T*-1) )))))))))
    (. .) ))
( (SINV 
    (S-TPC-1 
      (SBAR-ADV (IN While) 
        (S 
          (NP-SBJ (NNS universities) )
          (VP (VBP develop) 
            (NP (DT the) (JJ basic) (NN research) ))))
      (, ,) (`` ``) 
      (NP-SBJ (NN venture) (NNS capitalists) )
      (VP (VBP are) 
        (NP-PRD 
          (NP (DT the) (NNS ones) )
          (VP 
            (ADVP (RB best) )
            (VBD positioned) 
            (S 
              (NP-SBJ (-NONE- *) )
              (VP (TO to) 
                (VP (VB finance) 
                  (NP (PRP$ its) (NN commercialization) ))))))))
    (, ,) ('' '') 
    (VP (VBZ says) 
      (S (-NONE- *T*-1) ))
    (NP-SBJ 
      (NP (NNP Gloria) (NNP W.) (NNP Doubleday) )
      (PP (IN of) 
        (NP (NNP Commonwealth) )))
    (. .) ))
( (S (`` ``) 
    (NP-SBJ (DT This) )
    (VP (VBZ is) 
      (NP-PRD 
        (NP (DT the) (JJS best) (NN way) )
        (SBAR 
          (WHADVP-1 (-NONE- 0) )
          (S 
            (NP-SBJ (-NONE- *) )
            (VP (TO to) 
              (VP (VB transfer) 
                (NP (NN technology) )
                (PP-CLR (RB straight) (IN off) 
                  (NP 
                    (NP (DT the) (NNS campuses) )
                    (PP (IN of) 
                      (NP (NNS universities) ))))
                (ADVP-MNR (-NONE- *T*-1) )))))))
    (. .) ('' '') ))
( (S 
    (S-TPC-2 (CC But) 
      (NP-SBJ (DT the) (JJ new) (NNS guidelines) )
      (VP (MD could) 
        (VP (VB prevent) 
          (NP-3 
            (NP (NNS scientists) )
            (PP (IN like) 
              (NP (NNP Prof.) (NNP Schimmel) )))
          (PP-CLR (IN from) 
            (S-NOM 
              (NP-SBJ-1 (-NONE- *-3) )
              (VP (VBG being) 
                (VP (VBN involved) 
                  (NP (-NONE- *-1) )
                  (PP-CLR (IN with) 
                    (NP 
                      (NP (NNS start-ups) )
                      (PP (JJ such) (IN as) 
                        (NP (NNP Amira) ))))))))))
      (, ,) )
    (NP-SBJ (NN venture) (NNS capitalists) )
    (VP (VBP point) 
      (PRT (RP out) )
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-2) )))
    (. .) ))
( (S 
    (S-TPC-2 (CC And) 
      (SBAR-ADV (IN if) 
        (S 
          (NP-SBJ (DT that) )
          (VP (VBZ happens) )))
      (, ,) 
      (NP-SBJ-1 
        (NP (DT the) (JJ entire) (NN process) )
        (PP (IN of) 
          (S-NOM 
            (NP-SBJ (-NONE- *) )
            (VP (VBG transferring) 
              (NP (NN technology) )
              (PP-DIR (TO to) 
                (NP (DT the) (NN marketplace) ))))))
      (VP (MD could) 
        (VP (VB be) 
          (VP (VBN harmed) 
            (NP (-NONE- *-1) ))))
      (, ,) )
    (NP-SBJ (PRP they) )
    (VP (VBP say) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-2) )))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (DT The) (NNS stakes) )
      (PP-LOC (IN in) 
        (NP (DT the) (NN controversy) )))
    (VP (VBP are) 
      (ADJP-PRD (JJ large) ))
    (. .) ))
( (S 
    (NP-TMP (JJ Last) (NN year) )
    (, ,) 
    (NP-SBJ-1 (NN venture) (NNS capitalists) )
    (VP (VBD spent) 
      (NP (DT an) 
        (QP (VBN estimated) ($ $) (CD 600) (CD million) )
        (-NONE- *U*) )
      (S-PRP-CLR 
        (NP-SBJ (-NONE- *-1) )
        (VP (TO to) 
          (VP (VB finance) 
            (NP (JJ start-up) (NNS companies) )
            (PP-LOC (IN in) 
              (NP 
                (UCP (JJ medical) 
                  (CC and)
                  (NN biotechnology) )
                (NNS businesses) )))))
      (, ,) 
      (PP (VBG according) 
        (PP (TO to) 
          (NP 
            (NP (DT the) (NNP National) (NNP Venture) (NNP Capital) (NNP Association) )
            (, ,) 
            (NP (DT a) (NN trade) (NN group) )))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (JJ Many) )
      (PP (IN of) 
        (NP (DT the) (NNS deals) )))
    (VP (VBD involved) 
      (NP 
        (NP (NNS transactions) )
        (SBAR 
          (WHPP-1 (IN in) 
            (WHNP (WDT which) ))
          (S 
            (NP-SBJ-2 (JJ scientific) (NNS institutions) (CC or) (NNS researchers) )
            (VP (VBN agreed) 
              (S 
                (NP-SBJ (-NONE- *-2) )
                (VP (TO to) 
                  (VP (VB commercialize) 
                    (NP (PRP$ their) (NN work) ))))
              (PP (IN in) 
                (NP 
                  (NP (NN return) )
                  (PP (IN for) 
                    (NP 
                      (NP (DT an) (NN equity) (NN stake) )
                      (CC or) 
                      (NP (NNS royalties) )))))
              (PP-LOC (-NONE- *T*-1) ))))))
    (. .) ))
((SINV 
    (S-TPC-1 
      (PP-LOC (IN In) 
        (NP 
          (NP (DT many) )
          (PP (IN of) 
            (NP (DT these) (VBZ deals) ))))
      (, ,) (`` ``) 
      (NP-SBJ (NN venture) (NNS capitalists) )
      (VP (VBD had) 
        (NP (DT the) (NN inside) (NN track) )))
    (, ,) ('' '') 
    (VP (VBZ says) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (NP-SBJ 
      (NP (NNP Lawrence) (NNP Bock) )
      (PP (IN of) 
        (NP 
          (NP (NNP Avalon) (NNP Ventures) )
          (, ,) 
          (NP-LOC 
            (NP (NNP La) (NNP Jolla) )
            (, ,) 
            (NP (NNP Calif) )))))
    (. .) ))
( (S 
    (S-TPC-2 
      (NP-SBJ-1 (NNS Investors) )
      (VP (VBD were) 
        (ADJP-PRD (JJ willing) 
          (S 
            (NP-SBJ (-NONE- *-1) )
            (VP (TO to) 
              (VP (VB gamble) 
                (PP-CLR (IN on) 
                  (NP (JJ new) (NNS technologies) ))
                (SBAR-PRP (IN because) (`` ``) 
                  (S 
                    (NP-SBJ (PRP we) )
                    (VP (VBD had) 
                      (NP 
                        (NP (JJ exclusive) (NNS rights) )
                        (PP (TO to) 
                          (NP (DT those) (NNS technologies) ))))))))))))
    (, ,) ('' '') 
    (NP-SBJ (PRP he) )
    (VP (VBZ adds) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-2) )))
    (. .) ))
( (S (CC But) 
    (PP-LOC (IN under) 
      (NP (DT the) (VBN proposed) (NNS guidelines) ))
    (, ,) 
    (NP-SBJ-2 (DT all) 
      (ADJP (RB federally) (VBN funded) )
      (NN research) )
    (VP (MD will) 
      (VP (VB have) 
        (S 
          (NP-SBJ-1 (-NONE- *-2) )
          (VP (TO to) 
            (VP (VB be) 
              (VP (VBN reported) 
                (NP (-NONE- *-1) )
                (ADVP-MNR (RB publicly) )
                (SBAR-PRP (IN so) (IN that) 
                  (S 
                    (NP-SBJ (NN anyone) )
                    (VP (MD can) 
                      (VP (VB capitalize) 
                        (PP-CLR (IN on) 
                          (NP (DT the) (NN work) ))))))))))))
    (. .) ))
( (S (`` ``) 
    (S-TPC-1 
      (PP (IN Without) 
        (NP (DT the) (NN exclusivity) ))
      (, ,) 
      (NP-SBJ (JJS most) (NN venture) (NNS capitalists) )
      (VP (MD wo) (RB n't) 
        (VP (VB have) 
          (NP (DT the) (NN incentive) 
            (S 
              (NP-SBJ (-NONE- *) )
              (VP (TO to) 
                (VP (VB invest) 
                  (PP-CLR (IN in) 
                    (NP (JJ such) (NNS deals) )))))))))
    (, ,) ('' '') 
    (NP-SBJ (NNP Mr.) (NNP Bock) )
    (VP (VBZ says) 
      (S (-NONE- *T*-1) ))
    (. .) ))
( (S 
    (NP-TMP (JJ Last) (NN year) )
    (, ,) 
    (PP (IN for) 
      (NP (NN example) ))
    (, ,) 
    (NP-SBJ-1 (NNP Avalon) 
      (CC and)
      (NNS others) )
    (VP (VBD invested) 
      (NP 
        (QP ($ $) (CD 14) (CD million) )
        (-NONE- *U*) )
      (PP-LOC-CLR (IN in) 
        (NP 
          (NP (NNP Athena) (NNP Neurosciences) (NNP Inc.) )
          (, ,) 
          (NP-LOC 
            (NP (NNP South) (NNP San) (NNP Francisco) )
            (, ,) 
            (NP (NNP Calif.) ))))
      (, ,) 
      (S-PRP 
        (NP-SBJ (-NONE- *-1) )
        (VP (TO to) 
          (VP (VB license) 
            (CC and)
            (VB develop) 
            (NP 
              (NP (NN technology) )
              (PP (IN for) 
                (NP 
                  (NP (NN delivery) )
                  (PP (IN of) 
                    (NP (NNS drugs) ))
                  (PP (TO to) 
                    (NP (DT the) (NN brain) )))))))))
    (. .) ))
( (S 
    (S-TPC-2 (CC But) 
      (SBAR-TMP (IN before) 
        (S 
          (NP-SBJ-1 (NNP Athena) )
          (VP (VBD was) 
            (ADJP-PRD (JJ able) 
              (S 
                (NP-SBJ (-NONE- *-1) )
                (VP (TO to) 
                  (VP (VB get) 
                    (NP 
                      (NP (DT an) (JJ exclusive) (NN license) )
                      (PP (TO to) 
                        (NP (DT the) (NN technology) ))))))))))
      (, ,) 
      (NP-SBJ (DT the) (NNP Federal) (NNP Register) )
      (VP (VBD published) 
        (NP 
          (NP (JJS most) )
          (PP (IN of) 
            (NP (DT the) (NNS details) )))
        (, ,) (`` ``) 
        (S-ADV 
          (NP-SBJ (-NONE- *) )
          (VP (VBG giving) 
            (NP 
              (NP (DT all) )
              (PP (IN of) 
                (NP 
                  (NP (DT the) (NN company) (POS 's) )
                  (JJ potential) (NNS competitors) )))
            (NP (DT a) (NN chance) 
              (S 
                (NP-SBJ (-NONE- *) )
                (VP (TO to) 
                  (VP (VB exploit) 
                    (NP (PRP it) )))))))))
    (, ,) ('' '') 
    (NP-SBJ (NNP Mr.) (NNP Bock) )
    (VP (VBZ says) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-2) )))
    (. .) ))
( (S 
    (NP-SBJ (NNP Athena) )
    (VP 
      (VP 
        (ADVP-TMP (RB eventually) )
        (VBD acquired) 
        (NP 
          (NP (JJ exclusive) (NNS rights) )
          (PP (TO to) 
            (NP (DT the) (NN technology) ))))
      (CC and) 
      (VP 
        (ADVP-TMP (RB currently) )
        (VBZ is) 
        (VP (VBG developing) 
          (NP (PRP it) ))))
    (. .) ))
( (SINV (CC But) 
    (, ,)
    (VP (VBZ says) 
      (S (-NONE- *ICH*-1) ))
    (NP-SBJ (NNP Mr.) (NNP Bock) )
    (, ,) (`` ``) 
    (S-1 
      (NP-SBJ (PRP It) )
      (VP (VBD was) 
        (NP-PRD (DT a) (JJ close) (NN call) )))
    (. .) ('' '') ))
( (S 
    (S-TPC-1 
      (NP-SBJ (DT The) (VBN proposed) (NNS guidelines) )
      (VP (MD could) 
        (ADVP (RB also) )
        (VP 
          (VP (VB delay) 
            (NP (NN commercialization) ))
          (: --) 
          (CC and)
          (VP (VB force) 
            (S 
              (NP-SBJ (JJ small) (NNS companies) )
              (VP (TO to) 
                (VP (VB waste) 
                  (NP (JJ scarce) (NN capital) ))))))))
    (, ,) 
    (NP-SBJ (NNS entrepreneurs) )
    (VP (VBP say) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (. .) ))
( (SINV 
    (S-TPC-1 
      (SBAR-ADV (IN If) 
        (S 
          (NP-SBJ (NNS start-ups) )
          (VP (MD ca) (RB n't) 
            (VP (VB have) 
              (NP 
                (NP (JJ early) (NN access) )
                (PP (TO to) 
                  (NP 
                    (NP (NN research) )
                    (VP (NN being) 
                      (VP (VBN conducted) 
                        (NP (-NONE- *) )
                        (PP-LOC (IN at) 
                          (NP (NNS institutions) )))))))))))
      (, ,) (`` ``) 
      (NP-SBJ-2 (PRP we) )
      (VP (VBP have) 
        (S 
          (NP-SBJ (-NONE- *-2) )
          (VP (TO to) 
            (VP 
              (VP (VB replicate) 
                (NP (PRP it) )
                (NP-ADV (PRP ourselves) ))
              (CC or) 
              (VP (VB do) 
                (PP-CLR (IN without) 
                  (NP (DT the) (NN research) ))))))))
    (, ,) ('' '') 
    (VP (VBZ says) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (NP-SBJ 
      (NP (NNP Ruth) (NNP Emyanitoff) )
      (, ,) 
      (NP 
        (NP (NN manager) )
        (PP (IN of) 
          (NP (NN business) (NN development) ))
        (PP-LOC (IN at) 
          (NP 
            (NP (NNP Applied) (NNP bioTechnology) (NNP Inc.) )
            (, ,) 
            (NP (DT a) 
              (NAC-LOC (NNP Cambridge) 
                (, ,)
                (NNP Mass.) 
                (, ,)
                )
              (NN concern) )))))
    (. .) ))
( (S 
    (S-TPC-1 
      (S-NOM-SBJ 
        (NP-SBJ (-NONE- *) )
        (VP (VBG Duplicating) 
          (NP (NN research) )))
      (VP (VBZ is) 
        (ADJP-PRD (DT both) (JJ costly) 
          (CC and)
          (JJ time-consuming) )
        (PP (IN for) 
          (NP (DT a) (NN start-up) ))))
    (, ,) 
    (NP-SBJ (NNP Ms.) (NNP Emyanitoff) )
    (VP (VBZ says) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (. .) ))
( (S 
    (PP (IN For) 
      (NP (PRP$ its) (NN part) ))
    (, ,) 
    (NP-SBJ (NNP NIH) )
    (VP (VBZ insists) 
      (SBAR (IN that) 
        (S 
          (NP-SBJ (PRP$ its) (NNS guidelines) )
          (`` ``) 
          (VP (MD should) (RB not) 
            (VP (VB stifle) 
              (NP 
                (NP (NN research) (NN creativity) )
                (CC or) 
                (NP 
                  (NP (NN technology) (NN transfer) )
                  (PP (IN from) 
                    (NP (DT the) (NN research) (NN laboratory) ))
                  (PP (TO to) 
                    (NP (JJ commercial) (NN use) )))))))))
    (. .) ('' '') ))
((SINV 
    (S-TPC-4 
      (NP-SBJ-2 
        (NP (NNS Universities) )
        (PP (JJ such) (IN as) 
          (NP (NNP Harvard) 
            (CC and)
            (NNP MIT) )))
      (VP (MD should) 
        (VP (VB be) 
          (ADJP-PRD (JJ able) 
            (S 
              (NP-SBJ (-NONE- *-2) )
              (VP (TO to) 
                (VP (VB develop) 
                  (NP 
                    (NP (DT a) (NN way) )
                    (SBAR 
                      (WHADVP-3 (-NONE- 0) )
                      (S 
                        (NP-SBJ (-NONE- *) )
                        (VP (TO to) 
                          (VP (VB act) 
                            (PP-CLR (IN as) 
                              (NP 
                                (NP (NNS brokers) )
                                (PP (IN for) 
                                  (NP (DT the) (JJ individual) (NNS scientists) ))))
                            (ADVP-MNR (-NONE- *T*-3) )))))))))))))
    (, ,) 
    (VP (VBZ says) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-4) )))
    (NP-SBJ 
      (NP (NNP Katherine) (NNP Bick) )
      (, ,) 
      (SBAR 
        (WHNP-1 (WP who) )
        (S 
          (NP-SBJ (-NONE- *T*-1) )
          (VP (VBZ oversees) 
            (NP (DT the) (JJ huge) (NNP NIH) (NNS grants) (NN program) )
            (PP-MNR (IN as) 
              (NP 
                (NP (PRP$ its) (NN deputy) (NN director) )
                (PP (IN for) 
                  (NP (JJ extramural) (NN research) ))))))))
    (. .) ))
( (S 
    (NP-SBJ (NNP NIH) (NN staff) (NNS members) )
    (VP (VBP believe) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ-2 (DT the) (NNS guidelines) )
          (VP (VBP are) 
            (ADJP-PRD (JJ essential) 
              (S 
                (NP-SBJ (-NONE- *-2) )
                (VP (TO to) 
                  (VP (VB prevent) 
                    (NP 
                      (NP (DT the) (NN escalation) )
                      (PP (IN of) 
                        (NP 
                          (NP (NNS problems) )
                          (SBAR 
                            (WHNP-1 (WDT that) )
                            (S 
                              (NP-SBJ-3 (-NONE- *T*-1) )
                              (VP (VBP have) 
                                (ADVP (RB already) )
                                (VP (VBN begun) 
                                  (S 
                                    (NP-SBJ (-NONE- *-3) )
                                    (VP (TO to) 
                                      (VP (VB surface) 
                                        (PP-LOC (IN in) 
                                          (NP (JJ scientific) (NNS ventures) ))))))))))))))))))))
    (. .) ))
( (S 
    (ADVP-TMP (RB Not) (RB long) (RB ago) )
    (, ,) 
    (NP-SBJ-1 
      (NP (NNS scientists) )
      (VP (VBG holding) 
        (NP 
          (NP (NN stock) )
          (PP-LOC (IN in) 
            (NP (NNP Spectra) (NNP Pharmaceutical) (NNPS Services) (NNP Inc.) )))))
    (VP (VBD were) 
      (VP (VBN accused) 
        (NP-2 (-NONE- *-1) )
        (PP-CLR (IN of) 
          (S-NOM 
            (NP-SBJ-3 (-NONE- *-2) )
            (VP (VBG falsifying) 
              (NP (NN research) )
              (S-PRP 
                (NP-SBJ (-NONE- *-3) )
                (VP (TO to) 
                  (VP (VB boost) 
                    (NP (DT the) (NN stock) )))))))))
    (. .) ))
( (S 
    (NP-SBJ (JJ Many) (NNS officials) )
    (VP (VBP are) 
      (ADVP (RB also) )
      (ADJP-PRD (VBN concerned) 
        (PP (IN about) 
          (NP 
            (NP (NNS companies) )
            (VP (VBG getting) 
              (NP 
                (NP (DT a) (`` ``) (JJ free) (NN ride) ('' '') )
                (PP (IN on) 
                  (NP (JJ government-sponsored) (NN research) ))))))))
    (. .) ))
( (S 
    (NP-SBJ (DT A) (JJ congressional) (NN subcommitee) )
    (VP (VBZ has) 
      (VP (VBN been) 
        (VP (VBG investigating) 
          (NP 
            (NP (DT the) (JJ potential) (NN abuse) )
            (PP (IN from) 
              (NP 
                (NP (NNS researchers) )
                (VP (VBG holding) 
                  (NP 
                    (NP (NN stock) )
                    (PP-LOC (IN in) 
                      (NP 
                        (NP (NNS companies) )
                        (VP (VBG exploiting) 
                          (NP (PRP$ their) (NN research) ))))))))))))
    (. .) ))
( (S 
    (PP (IN Among) 
      (NP (JJ other) (NNS provisions) ))
    (, ,) 
    (NP-SBJ (DT the) (NNP NIH) (NNS guidelines) )
    (VP (MD would) 
      (VP (VB prohibit) 
        (NP-3 
          (NP (NNS researchers) )
          (CC and) 
          (NP 
            (NP (NNS members) )
            (PP (IN of) 
              (NP (PRP$ their) (JJ immediate) (NNS families) ))))
        (PP-CLR (IN from) 
          (S-NOM 
            (NP-SBJ (-NONE- *-3) )
            (VP (VBG holding) 
              (NP 
                (NP (NN stock) )
                (PP-LOC (IN in) 
                  (NP 
                    (NP (DT any) (NN company) )
                    (SBAR 
                      (WHNP-2 (WDT that) )
                      (S 
                        (NP-SBJ-1 (-NONE- *T*-2) )
                        (VP (VBZ is) 
                          (VP (VBN affected) 
                            (NP (-NONE- *-1) )
                            (PP (IN by) 
                              (NP-LGS 
                                (NP (DT the) (NN outcome) )
                                (PP (IN of) 
                                  (NP (PRP$ their) (NN research) ))))))))))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (NNP Ms.) (NNP Bick) )
      (, ,) 
      (NP (DT the) (NNP NIH) (NN administrator) )
      (, ,) )
    (VP (VBZ says) 
      (SBAR (-NONE- 0) 
        (S 
          (NP-SBJ (DT the) 
            (UCP (NN business) 
              (CC and)
              (JJ scientific) )
            (NN community) )
          (VP (VBZ is) 
            (VP (VBG overreacting) 
              (PP-CLR (TO to) 
                (SBAR-NOM 
                  (WHNP-1 (WP what) )
                  (S 
                    (NP-SBJ (DT the) (NN agency) )
                    (ADVP (RB merely) )
                    (VP (VBD meant) 
                      (S 
                        (NP-SBJ (-NONE- *T*-1) )
                        (VP (TO to) 
                          (VP (VB be) (`` ``) 
                            (NP-PRD 
                              (NP (NNS ideas) )
                              (PP (IN for) 
                                (NP (NN discussion) )))))))))))))))
    (. .) ('' '') ))
( (S 
    (S-TPC-1 
      (NP-SBJ 
        (NP (DT The) (NNS predictions) )
        (PP (IN of) 
          (NP (NN doom) )))
      (VP (VBP are) (`` ``) 
        (ADJP-PRD (JJ premature) )))
    (, ,) ('' '') 
    (NP-SBJ (PRP she) )
    (VP (VBZ says) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-1) )))
    (. .) ))
( (S 
    (S-TPC-2 (CC But) 
      (SBAR-TMP 
        (WHADVP-1 (WRB when) )
        (S 
          (NP-SBJ 
            (NP (NNS agencies) )
            (PP (IN like) 
              (NP (DT the) (NNP NIH) )))
          (VP (VBP circulate) 
            (NP (NNS guidelines) )
            (ADVP-TMP (-NONE- *T*-1) ))))
      (, ,) 
      (NP-SBJ (PRP they) )
      (VP (VBP 've) 
        (ADVP-TMP (RB often) )
        (ADVP (RB already) )
        (VP (VBN formulated) 
          (NP (NN policy) ))))
    (, ,) 
    (NP-SBJ (NN veteran) (NNS scientists) )
    (VP (VBP say) 
      (SBAR (-NONE- 0) 
        (S (-NONE- *T*-2) )))
    (. .) ))
( (S 
    (ADVP (RB Indeed) )
    (, ,) 
    (NP-SBJ (NNS institutions) )
    (ADVP (RB already) )
    (VP (VBP are) 
      (VP (VBG taking) 
        (NP-CLR (NN note) )))
    (. .) ))
( (S 
    (PP-TMP (IN On) 
      (NP (NNP Sept.) (CD 14) ))
    (, ,) 
    (NP-SBJ-2 (NNP Harvard) )
    (VP (VBD began) 
      (S 
        (NP-SBJ (-NONE- *-2) )
        (VP (VBG circulating) 
          (NP 
            (NP (DT a) (JJ conflict-of-interest) (NN policy) (NN statement) )
            (SBAR 
              (WHNP-1 (IN that) )
              (, ,) 
              (S 
                (PP (IN in) 
                  (NP (NN effect) ))
                (, ,) 
                (NP-SBJ (-NONE- *T*-1) )
                (VP (MD would) 
                  (VP (VB follow) 
                    (NP (DT the) (NNP NIH) (NNS guidelines) )
                    (ADVP-MNR (RB faithfully) )))))))))
    (. .) ))
( (S 
    (NP-SBJ 
      (NP (DT The) (NNP University) )
      (PP (IN of) 
        (NP (NNP California) ))
      (PP-LOC (IN at) 
        (NP (NNP San) (NNP Francisco) )))
    (VP (VBZ is) 
      (ADVP (RB also) )
      (VP (VBG circulating) 
        (NP 
          (NP (DT a) (NN memo) )
          (SBAR (-NONE- *ICH*-1) ))
        (PP-CLR (IN among) 
          (NP (PRP$ its) (JJ scientific) (NN faculty) ))
        (SBAR-1 
          (WHNP-2 (WDT that) )
          (S 
            (NP-SBJ (-NONE- *T*-2) )
            (VP (MD will) 
              (VP (VB restrict) 
                (NP 
                  (NP (NN contact) )
                  (PP (IN with) 
                    (NP 
                      (NP (DT the) (NN world) )
                      (PP (IN of) 
                        (NP (NN business) )))))))))))
    (. .) ))
( (S 
    (PP-LOC (IN In) 
      (NP (JJ many) (JJ other) (NNS institutions) ))
    (, ,) 
    (NP-SBJ (NNS scientists) )
    (VP (VBP are) 
      (VP (VBG shunning) 
        (NP 
          (NP (NNS contacts) )
          (PP (IN with) 
            (NP (NN venture) (NNS investors) )))
        (SBAR-TMP (IN until) 
          (S 
            (NP-SBJ-1 (DT the) (NNP NIH) (NN policy) )
            (VP (VBZ is) 
              (VP (VBN settled) 
                (NP (-NONE- *-1) )))))))
    (. .) ))
( (SINV 
    (VP (VBZ Says) 
      (S (-NONE- *ICH*-1) ))
    (NP-SBJ 
      (NP (NNP Mr.) (NNP Daly) )
      (, ,) 
      (NP (DT the) (NN venture) (NN capitalist) ))
    (: :) (`` ``) 
    (S-1 
      (NP-SBJ 
        (NP (PRP It) )
        (SBAR (-NONE- *EXP*-2) ))
      (VP (VBZ does) (RB n't) 
        (VP (VB matter) 
          (SBAR-2 (IN whether) 
            (S 
              (NP-SBJ (PRP they) )
              (VP (VBP call) 
                (S 
                  (NP-SBJ (PRP it) )
                  (NP-PRD (NNS guidelines) (CC or) (NN policy) ))))))))
    (. .) ))
( (S 
    (NP-SBJ-1 (DT The) (NN damage) )
    (VP (VBZ is) 
      (ADVP (RB already) )
      (VP (VBN done) 
        (NP (-NONE- *-1) )))
    (. .) ))
